EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840

Reggie Bosma, Desislava Nesheva, Merel Rijnsburger, Rick Riemens, Justyna M Adamska, Max Meyrath, Simon Mobach, C Maurice Buzink, Suzanne van der Pol, Iwan J P de Esch, Martyna Szpakowska, Maikel Wijtmans und 3 weitere

Molecular Pharmacology · 2025-12 · 107 (12) · 100085

DOI: 10.1016/j.molpha.2025.100085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2025-12. Verfasst von Reggie Bosma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Amsterdam Institute for Molecular and Life Sciences (AIMMS), Faculty of Science, Vrije Universiteit Amsterdam, Ams…. Hauptthemen laut MEDLINE: Receptors, CXCR, Small Molecule Libraries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Fund, Health~Holland, Fondation Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCRSmall Molecule LibrariesHumansHEK293 CellsDrug Inverse AgonismAnimalsSignal Transduction

Stichwörter der Autor:innen

Atypical chemokine receptor 3CXCL11CXCL12Constitutive activityInverse agonist

Substanzen

ACKR3 protein, humanReceptors, CXCRSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Amsterdam Institute for Molecular and Life Sciences (AIMMS), Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • MS Center Amsterdam, Department of Molecular Cell Biology and Immunology, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Department of Medicinal Chemistry, Amsterdam Institute for Molecular and Life Sciences (AIMMS), Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Electronic address: r.leurs@vu.nl.

Förderung

  • National Research Fund
  • Health~Holland
  • Fondation Cancer

Zitieren

APA

Bosma, R., Nesheva, D., Rijnsburger, M., Riemens, R., Adamska, J. M., Meyrath, M., Mobach, S., Buzink, C. M., van der Pol, S., de Esch, I. J. P., Szpakowska, M., Wijtmans, M., Chevigne, A., Vischer, H. F., & Leurs, R. (2025). Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840. Molecular Pharmacology, 107(12), 100085. https://doi.org/10.1016/j.molpha.2025.100085

Vancouver

Bosma R, Nesheva D, Rijnsburger M, Riemens R, Adamska JM, Meyrath M, et al. Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840. Molecular Pharmacology. 2025;107(12):100085. doi:10.1016/j.molpha.2025.100085

BibTeX
@article{Bosma2025,
  author = {Bosma, Reggie and Nesheva, Desislava and Rijnsburger, Merel and Riemens, Rick and Adamska, Justyna M and Meyrath, Max and Mobach, Simon and Buzink, C Maurice and van der Pol, Suzanne and de Esch, Iwan J P and Szpakowska, Martyna and Wijtmans, Maikel and Chevigne, Andy and Vischer, Henry F and Leurs, Rob},
  title = {Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840},
  journal = {Molecular Pharmacology},
  year = {2025},
  volume = {107},
  number = {12},
  pages = {100085},
  doi = {10.1016/j.molpha.2025.100085}
}
Kostenlos starten →